Versant Capital Management’s RxSight RXST Stock Holding History

Versant Capital Management’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,132	Closed	-$27.7K	–	2708
2025 Q2	$27.7K	Buy	+2,132	New	+$32.1K	﹤0.01%	1335

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Versant Capital Management's RXST Position: Q3 2025 in Review

Versant Capital Management sold out of RxSight (RXST) in Q3 2025, closing a stake of 2,132 shares — an estimated $27.7K sold.

Versant Capital Management first reported a position in RXST in Q2 2025 and held it in 1 quarter. The position peaked at $27.7K in Q2 2025. 160 funds tracked by Wall St. Rank hold RXST as of Q3 2025.

Versant Capital Management reported no remaining RxSight position as of Q3 2025 after selling out during the quarter.
Versant Capital Management sold 2,132 RxSight shares in Q3 2025, an estimated $27.7K.
Versant Capital Management first reported a position in RxSight in Q2 2025 and held it in 1 quarter.
Versant Capital Management's RxSight position peaked at $27.7K in Q2 2025.
160 funds tracked by Wall St. Rank held RxSight as of Q3 2025.

Based on Versant Capital Management's 13F filing for Q3 2025, filed 27 Oct 2025.